Clinical Trial Update: Probiotics and Microbiota in Bariatric Surgery [NA]

View source ↗

Summary

Clinical trial update examining the effects of probiotics and gut microbiota in bariatric surgery patients, with a focus on non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Probiotics

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: NAFLD | NA | Status: UNKNOWN